YAP1 and hepatocellular carcinoma: For example, Xin Y. et al. (2020) noticed that being a transcriptional target of the Hippo-YAP/TAZ pathway miR-135b silences MST1 expression as an oncomiR, and consequently, the MST1-YAP-miR-135b axis generates a positive feedback loop in HCC advancement.